Mergers & AcquisitionsMedium•12 November 2026•
1 min read
Rockwell Medical Forecasts Up to $450M Annual Revenue Following Vantive Deal
Key Facts
1Rockwell Medical expects combined annual revenue of $400M-$450M following the targeted closing of the Vantive deal.
2The company is targeting mid-2027 for the closing of the Vantive acquisition.
Rockwell Medical expects combined annual revenue to range between $400 million and $450 million following the completion of the Vantive acquisition. Seeking Alpha reported that the company is targeting mid-2027 for the closing of the deal as it seeks to integrate operations and drive future growth.
RMTI closed at $7.08 on November 11, 2026, prior to the release of this guidance which reflects the company's strategic plan for its core hemodialysis business. These projections are based on the transformative impact the acquisition is expected to have on the company's overall revenue profile upon closing.